Imaging Response Assessment Teams
Imaging Response Assessment Teams (IRATs) work to advance the role of imaging in assessment of response to therapy and to increase the application of quantitative anatomic, functional, and molecular imaging endpoints in clinical therapeutic trials.

The IRAT Network and project, supported by the National Cancer Institute, aim to strengthen clinical collaboration between imaging scientists and oncologic investigators; integrate IRAT teams into the protocol planning process of clinical trial design; and facilitate an ongoing exchange of ideas that will serve to advance the role of imaging as a biomarker in the oncology community.